Navigation Links
Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
Date:4/28/2008

EVANSTON, Ill., April 28 /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. (Nasdaq: NFLD). Northfield Laboratories Inc. issued the following statement in response to a May 21 publication in the Journal of the American Medical Association entitled Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis and the accompanying editorial released online today.

"Meta-analyses that compare varied products under the umbrella of an entire class are a useful tool to raise questions that may merit answers with respect to the class," said Steven A. Gould, M.D., Chairman and Chief Executive Officer of Northfield Laboratories, Inc. "But it is important to note what meta-analyses cannot accomplish. Meta-analysis is not designed to provide answers about specific products or to examine fully the risk/benefit ratio of any particular product. Rather, that is the role of clinical trials that are focused on a particular product and are conducted to assess its safety and efficacy in relation to a proposed indication. Northfield will present such data on its product, PolyHeme(R) next week at the FDA/NIH-sponsored workshop on Hemoglobin Based Oxygen Carriers (HBOCs.)"

The workshop, sponsored jointly by the Food and Drug Administration and the National Institutes of Health, will be held on April 28 and 29 in Bethesda, Maryland. It will examine the current status and future directions of HBOCs. Steven A. Gould, M.D., will present a talk on the clinical development of PolyHeme(R), Northfield Laboratories' investigational red cell substitute. His talk will include a summary of the clinical studies conducted by the Company and reported to the FDA.

About the Workshop

The two-day public workshop, Hemoglobin-Based Oxygen Carriers: Current Status and Future Directions, is sponsored by the Food and Drug Administration, the National Heart, Lung and Blood Institute of the National Institutes of Health, and the Department of Health and Human Services' Office of the Secretary and Office of Public Health and Science (OS/OPHS). The purpose of the workshop is to gather the available scientific information and hear informed opinion on the safety of HBOCs in relation to a variety of clinical use settings as a basis to advance the field.

About Northfield Laboratories and PolyHeme(R)

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield's product, PolyHeme(R), is under clinical investigation as oxygen-carrying red blood cell substitute. It is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit http://www.northfieldlabs.com.

FOR FURTHER INFORMATION CONTACT:

Sophia H. Twaddell

Vice President, Corporate Communications

(847) 864-3500

stwaddell@northfieldlabs.com


'/>"/>
SOURCE Northfield Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
2. NIOXIN(R) Research Laboratories First to Market HairDX Genetic Test for Womens Hair Loss
3. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
6. Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories (West Caldwell, NJ)
7. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings
8. Stiefel Laboratories Appoints First Chief Scientific Officer
9. Underwriters Laboratories Management System Registration Business to Merge With Germanys DQS
10. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
11. Bond Laboratories First Quarter Fiscal 2008 Sales Exceeding Internal Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: